In the first pathway, anti-CD47 antibody disrupts anti−engulfment signal, promoting M1/M2 macrophages-mediated phagocytosis and shifting the immunosuppressive phenotype of tumor-associated macrophages (TAMs) toward M1 subtype in vivo (32, 56). This evidence concerns the gene CD47 and neoplasm.